Related Experiment Videos
Obesity and coronary heart disease. A targeted approach
Arteriosclerosis (Dallas, Tex.)
|May 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proteinuria and lipoprotein lipase activity in Miniature Schnauzer dogs with and without hypertriglyceridemia.
Veterinary journal (London, England : 1997)·2016
A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.
Journal of lipid research·2008
Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Journal of internal medicine·2006
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.
Journal of internal medicine·2006
Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women.
Arteriosclerosis, thrombosis, and vascular biology·2002
Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes.
Arteriosclerosis (Dallas, Tex.)·1990
Vascular responses to endothelin-1 in atherosclerotic primates.
Arteriosclerosis (Dallas, Tex.)·1990
Effect of dietary fish oil on coronary artery and aortic atherosclerosis in African green monkeys.
Arteriosclerosis (Dallas, Tex.)·1990
Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism.
Arteriosclerosis (Dallas, Tex.)·1990
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Arteriosclerosis (Dallas, Tex.)·1990
Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.
Arteriosclerosis (Dallas, Tex.)·1990
A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.
Marine life science & technology·2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal of molecular and cellular cardiology plus·2026